Blog

• 
• 
• 
• 

Vanderbilt faculty, staff and students with innovative ideas and entrepreneurial aspirations will have additional support during the 2013-14 academic year.

An innovative wafer inspection tool developed by a team of Vanderbilt professors and engineers has been licensed exclusively to startup company Femtometrix. 

The Wall Street Journal recently featured “organs on a chip”, an innovative practice that is helping researchers around the globe dive into a new world of drug discovery.

Congratulations to a Vanderbilt research collaborator on receiving Medicare approval of a diagnostic test for patients with advanced non-small cell lung cancer (NSCLC).

 "Supreme Court Says Human Genes Aren’t Patentable,” reads a June 13 headline on the Wall Street Journal website.

Last week, the Obama Administration announced a string of executive actions and legislative recommendations in an attempt to “protect innovators from frivolous litigation and ensure the highest-quality patents in our system,” as stated in the online White House Briefing Room.

The My Cancer Genome mobile app is now available on iTunes! MCG DrugList brings the benefits of the nation’s first online information, personalized cancer decision support tool right to your mobile device.

Life Sciences Tennessee released a press release earlier this week about new legislation that many hope will have a positive impact on the biotech industry and the local economy.

DiaTech Oncology, a Brentwood-based clinical pathology lab that licensed technology from Vanderbilt in 2009, is popping up in local and national publications after announcing it has secured $18 million in venture financing from investors.

May proved to be rewarding month for Vanderbilt inventors with five patents issued.